Art
J-GLOBAL ID:201502205736014603   Reference number:15A1407222

Chemoradiotherapy for pancreatic cancer

膵癌放射線療法の現状と展望
Author (1):
Material:
Volume: 112  Issue: 12  Page: 2127-2134 (J-STAGE)  Publication year: 2015 
JST Material Number: F0892A  ISSN: 0446-6586  CODEN: NIPAA  Document type: Article
Article type: 解説  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1407222&from=J-GLOBAL&jstjournalNo=F0892A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Radiotherapy for tumors 
Reference (44):
  • 1) Moertel CG, Childs DS Jr, Reitemeier RJ, et al: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2; 865-867: 1969
  • 2) Moertel CG, Frytak S, Hahn RG, et al: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluorouracil), and high dose radiation+5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 48; 1705-1710: 1981
  • 3) Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst 80; 751-755: 1988
  • 4) Burris HA 3rd, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15; 2403-2413: 1997
  • 5) Loehrer PJ Sr, Feng Y, Cardenes H, et al: Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol 29; 4105-4112: 2011
more...
Terms in the title (4):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page